[1] |
Jema A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
|
[2] |
陈万青,郑荣寿,张思维,等.2013年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2017,26(1):1-7.
|
[3] |
郑智,曹晓恩,张红萍.高危型HPV E6/E7 mRNA检测对高级别宫颈病变的诊断价值[J].浙江医学,2016,38(14):1154-1157.
|
[4] |
Walboomers JM,Jacobs MV,Manos MM,et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol,1999,189(1):12-19.
|
[5] |
zur Hausen H.Papillomaviruses and cancer:from basic studies to clinical application[J].Nat Rev Cancer,2002,2(5):342-350.
|
[6] |
耿建祥,黄华艺,刘建华,等.HPV感染疾病相关问题专家共识(2017)[J].医学研究生学报,2017,30(12):1238-1241.
|
[7] |
Forman D,De MC,Lacey CJ,et al.Global burden of human papillomavirus and related diseases[J].Vaccine,2012,30(9):F12-23.
|
[8] |
Serrano B,Alemany L,Ruiz PA,et al.Potentialimpact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries(Brazil,Mexico,India and China)[J].Cancer Epidemiol,2014,38(6):748-756.
|
[9] |
乔友林,赵宇倩.宫颈癌的流行病学现状和预防[J].中华妇幼临床医学杂志(电子版),2015,11(2):1-6.
|
[11] |
徐玲,杜雨璇,宁莉,等.赣州地区医院机会性筛查人群HR-HPV感染情况及其与宫颈病变关系的研究[J].江西医药,2018,53(10):92-96.
|
[12] |
唐争翠,李荣,唐争艳.池州地区HPV感染的基因型分布特点和宫颈病变情况分析[J].川北医学院学报,2019,34(4):407-410.
|
[10] |
Wang R,Guo XL,Wisman GB,et al.Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China[J].BMC Infect Dis,2015,15:257.
|
[13] |
王瑾,金光玉,葛小丽,等.六安地区高危型人乳头瘤病毒亚型分布特点及年龄分布特征[J].临床与实验病理学杂志,2018,34(8):904-906.
|
[14] |
吴凯.福建地区女性HPV感染的流行病学特征与宫颈早期病变的关系[J].临床合理用药杂志,2019,12(22):165-167.
|
[15] |
姜锦贵,夏林,耿建祥,等.HPV感染基因型与宫颈鳞癌致癌性关系的多中心回顾性研究[J].中国妇幼保健,2017,32(6):1141-1144.
|
[16] |
Kurman RJ,Carcangiu ML,Herrington CS,et al.WHO classification of tumours of female reproductive organs[M].4thed.Lyon:IARC Press,2014:172-176.
|
[17] |
郎景和.精确筛查风险分层HPV与子宫颈癌防治[J].中华妇产科杂志,2014,49(10):746-748.
|
[18] |
Katki HA,Schiffman M,Castle PE,et al.Five-year risks of CIN 3+and cervical cancer among women with HPV testing of ASC-US Pap results[J].J Low Genit Tract Dis,2013,17(5 Suppl 1):S36-S42.
|